A fluorescence-based thermal shift assay identifies inhibitors of mitogen activated protein kinase kinase 4.
Prostate cancer (PCa) is the second highest cause of cancer death in United States males. If the metastatic movement of PCa cells could be inhibited, then mortality from PCa could be greatly reduced. Mitogen-activated protein kinase kinase 4 (MAP2K4) has previously been shown to activate pro-invasio...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3855329?pdf=render |
id |
doaj-c86885c335784819b003c0a64c83d835 |
---|---|
record_format |
Article |
spelling |
doaj-c86885c335784819b003c0a64c83d8352020-11-25T01:52:50ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-01812e8150410.1371/journal.pone.0081504A fluorescence-based thermal shift assay identifies inhibitors of mitogen activated protein kinase kinase 4.Sankar N KrishnaChi-Hao LuanRama K MishraLi XuKarl A ScheidtWayne F AndersonRaymond C BerganProstate cancer (PCa) is the second highest cause of cancer death in United States males. If the metastatic movement of PCa cells could be inhibited, then mortality from PCa could be greatly reduced. Mitogen-activated protein kinase kinase 4 (MAP2K4) has previously been shown to activate pro-invasion signaling pathways in human PCa. Recognizing that MAP2K4 represents a novel and validated therapeutic target, we sought to develop and characterize an efficient process for the identification of small molecules that target MAP2K4. Using a fluorescence-based thermal shift assay (FTS) assay, we first evaluated an 80 compound library of known kinase inhibitors, thereby identifying 8 hits that thermally stabilized MAP2K4 in a concentration dependent manner. We then developed an in vitro MAP2K4 kinase assay employing the biologically relevant downstream substrates, JNK1 and p38 MAPK, to evaluate kinase inhibitory function. In this manner, we validated the performance of our initial FTS screen. We next applied this approach to a 2000 compound chemically diverse library, identified 7 hits, and confirmed them in the in vitro kinase assay. Finally, by coupling our structure-activity relationship data to MAP2K4's crystal structure, we constructed a model for ligand binding. It predicts binding of our identified inhibitory compounds to the ATP binding pocket. Herein we report the creation of a robust inhibitor-screening platform with the ability to inform the discovery and design of new and potent MAP2K4 inhibitors.http://europepmc.org/articles/PMC3855329?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sankar N Krishna Chi-Hao Luan Rama K Mishra Li Xu Karl A Scheidt Wayne F Anderson Raymond C Bergan |
spellingShingle |
Sankar N Krishna Chi-Hao Luan Rama K Mishra Li Xu Karl A Scheidt Wayne F Anderson Raymond C Bergan A fluorescence-based thermal shift assay identifies inhibitors of mitogen activated protein kinase kinase 4. PLoS ONE |
author_facet |
Sankar N Krishna Chi-Hao Luan Rama K Mishra Li Xu Karl A Scheidt Wayne F Anderson Raymond C Bergan |
author_sort |
Sankar N Krishna |
title |
A fluorescence-based thermal shift assay identifies inhibitors of mitogen activated protein kinase kinase 4. |
title_short |
A fluorescence-based thermal shift assay identifies inhibitors of mitogen activated protein kinase kinase 4. |
title_full |
A fluorescence-based thermal shift assay identifies inhibitors of mitogen activated protein kinase kinase 4. |
title_fullStr |
A fluorescence-based thermal shift assay identifies inhibitors of mitogen activated protein kinase kinase 4. |
title_full_unstemmed |
A fluorescence-based thermal shift assay identifies inhibitors of mitogen activated protein kinase kinase 4. |
title_sort |
fluorescence-based thermal shift assay identifies inhibitors of mitogen activated protein kinase kinase 4. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2013-01-01 |
description |
Prostate cancer (PCa) is the second highest cause of cancer death in United States males. If the metastatic movement of PCa cells could be inhibited, then mortality from PCa could be greatly reduced. Mitogen-activated protein kinase kinase 4 (MAP2K4) has previously been shown to activate pro-invasion signaling pathways in human PCa. Recognizing that MAP2K4 represents a novel and validated therapeutic target, we sought to develop and characterize an efficient process for the identification of small molecules that target MAP2K4. Using a fluorescence-based thermal shift assay (FTS) assay, we first evaluated an 80 compound library of known kinase inhibitors, thereby identifying 8 hits that thermally stabilized MAP2K4 in a concentration dependent manner. We then developed an in vitro MAP2K4 kinase assay employing the biologically relevant downstream substrates, JNK1 and p38 MAPK, to evaluate kinase inhibitory function. In this manner, we validated the performance of our initial FTS screen. We next applied this approach to a 2000 compound chemically diverse library, identified 7 hits, and confirmed them in the in vitro kinase assay. Finally, by coupling our structure-activity relationship data to MAP2K4's crystal structure, we constructed a model for ligand binding. It predicts binding of our identified inhibitory compounds to the ATP binding pocket. Herein we report the creation of a robust inhibitor-screening platform with the ability to inform the discovery and design of new and potent MAP2K4 inhibitors. |
url |
http://europepmc.org/articles/PMC3855329?pdf=render |
work_keys_str_mv |
AT sankarnkrishna afluorescencebasedthermalshiftassayidentifiesinhibitorsofmitogenactivatedproteinkinasekinase4 AT chihaoluan afluorescencebasedthermalshiftassayidentifiesinhibitorsofmitogenactivatedproteinkinasekinase4 AT ramakmishra afluorescencebasedthermalshiftassayidentifiesinhibitorsofmitogenactivatedproteinkinasekinase4 AT lixu afluorescencebasedthermalshiftassayidentifiesinhibitorsofmitogenactivatedproteinkinasekinase4 AT karlascheidt afluorescencebasedthermalshiftassayidentifiesinhibitorsofmitogenactivatedproteinkinasekinase4 AT waynefanderson afluorescencebasedthermalshiftassayidentifiesinhibitorsofmitogenactivatedproteinkinasekinase4 AT raymondcbergan afluorescencebasedthermalshiftassayidentifiesinhibitorsofmitogenactivatedproteinkinasekinase4 AT sankarnkrishna fluorescencebasedthermalshiftassayidentifiesinhibitorsofmitogenactivatedproteinkinasekinase4 AT chihaoluan fluorescencebasedthermalshiftassayidentifiesinhibitorsofmitogenactivatedproteinkinasekinase4 AT ramakmishra fluorescencebasedthermalshiftassayidentifiesinhibitorsofmitogenactivatedproteinkinasekinase4 AT lixu fluorescencebasedthermalshiftassayidentifiesinhibitorsofmitogenactivatedproteinkinasekinase4 AT karlascheidt fluorescencebasedthermalshiftassayidentifiesinhibitorsofmitogenactivatedproteinkinasekinase4 AT waynefanderson fluorescencebasedthermalshiftassayidentifiesinhibitorsofmitogenactivatedproteinkinasekinase4 AT raymondcbergan fluorescencebasedthermalshiftassayidentifiesinhibitorsofmitogenactivatedproteinkinasekinase4 |
_version_ |
1724992574273355776 |